News

A longitudinal study at Johns Hopkins that began in 1995 depends on the dedication of hundreds of people as well as NIH ...
Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.
Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...
The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...
Intranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a ...
Angela Craig spent her last days ill and frustrated as doctors in Colorado couldn’t pinpoint why she suddenly felt sluggish despite her active lifestyle.
Victim diagnosed with Alzheimer’s “My doctors have diagnosed me with Alzheimer’s after a brain PET scan 4 weeks ago revealed the characteristic findings,” Gasparro wrote.
A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer's disease treatments: Intranasal insulin, delivered via a simple nasal ...
Using a novel radiotracer, [68Ga]Ga-NOTA-insulin, delivered with a specialized six-spray nasal system, participants underwent a 40-minute brain PET scan followed by whole-body imaging.